308 related articles for article (PubMed ID: 35157535)
21. Recent Advances in the Use of Surface-Enhanced Raman Scattering for Illicit Drug Detection.
Azimi S; Docoslis A
Sensors (Basel); 2022 May; 22(10):. PubMed ID: 35632286
[TBL] [Abstract][Full Text] [Related]
22. Gold nanoparticles as a substrate in bio-analytical near-infrared surface-enhanced Raman spectroscopy.
Butler HJ; Fogarty SW; Kerns JG; Martin-Hirsch PL; Fullwood NJ; Martin FL
Analyst; 2015 May; 140(9):3090-7. PubMed ID: 25802895
[TBL] [Abstract][Full Text] [Related]
23. Developing and understanding biofluid vibrational spectroscopy: a critical review.
Baker MJ; Hussain SR; Lovergne L; Untereiner V; Hughes C; Lukaszewski RA; Thiéfin G; Sockalingum GD
Chem Soc Rev; 2016 Apr; 45(7):1803-18. PubMed ID: 26612430
[TBL] [Abstract][Full Text] [Related]
24. A rapid and label-free SERS detection method for biomarkers in clinical biofluids.
Kong KV; Leong WK; Lam Z; Gong T; Goh D; Lau WK; Olivo M
Small; 2014 Dec; 10(24):5030-4. PubMed ID: 25111592
[TBL] [Abstract][Full Text] [Related]
25. Vibration spectroscopy and body biofluids: Literature review for clinical applications.
Leal LB; Nogueira MS; Canevari RA; Carvalho LFCS
Photodiagnosis Photodyn Ther; 2018 Dec; 24():237-244. PubMed ID: 30282049
[TBL] [Abstract][Full Text] [Related]
26. Biofluid diagnostics by FTIR spectroscopy: A platform technology for cancer detection.
Sala A; Anderson DJ; Brennan PM; Butler HJ; Cameron JM; Jenkinson MD; Rinaldi C; Theakstone AG; Baker MJ
Cancer Lett; 2020 May; 477():122-130. PubMed ID: 32112901
[TBL] [Abstract][Full Text] [Related]
27. Trends in Application of SERS Substrates beyond Ag and Au, and Their Role in Bioanalysis.
Sultangaziyev A; Ilyas A; Dyussupova A; Bukasov R
Biosensors (Basel); 2022 Nov; 12(11):. PubMed ID: 36354477
[TBL] [Abstract][Full Text] [Related]
28. Surface-functionalized SERS platform for deep learning-assisted diagnosis of Alzheimer's disease.
Kim M; Huh S; Park HJ; Cho SH; Lee MY; Jo S; Jung YS
Biosens Bioelectron; 2024 May; 251():116128. PubMed ID: 38367567
[TBL] [Abstract][Full Text] [Related]
29. Tetrahydrocannabinol Sensing in Complex Biofluid with Portable Raman Spectrometer Using Diatomaceous SERS Substrates.
Sivashanmugan K; Zhao Y; Wang AX
Biosensors (Basel); 2019 Oct; 9(4):. PubMed ID: 31615082
[TBL] [Abstract][Full Text] [Related]
30. Enhancing Nonfouling and Sensitivity of Surface-Enhanced Raman Scattering Substrates for Potent Drug Analysis in Blood Plasma via Fabrication of a Flexible Plasmonic Patch.
Masterson AN; Hati S; Ren G; Liyanage T; Manicke NE; Goodpaster JV; Sardar R
Anal Chem; 2021 Feb; 93(4):2578-2588. PubMed ID: 33432809
[TBL] [Abstract][Full Text] [Related]
31. SERS immuno- and apta-assays in biosensing/bio-detection: Performance comparison, clinical applications, challenges.
Ilyas A; Dyussupova A; Sultangaziyev A; Shevchenko Y; Filchakova O; Bukasov R
Talanta; 2023 Dec; 265():124818. PubMed ID: 37453393
[TBL] [Abstract][Full Text] [Related]
32. Current and Future Advancements of Raman Spectroscopy Techniques in Cancer Nanomedicine.
Canetta E
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884946
[TBL] [Abstract][Full Text] [Related]
33. Using SERS-based microfluidic paper-based device (μPAD) for calibration-free quantitative measurement of AMI cardiac biomarkers.
Lim WY; Goh CH; Thevarajah TM; Goh BT; Khor SM
Biosens Bioelectron; 2020 Jan; 147():111792. PubMed ID: 31678828
[TBL] [Abstract][Full Text] [Related]
34. Raman spectroscopy assisted tear analysis: A label free, optical approach for noninvasive disease diagnostics.
Thomas KM; Ajithaprasad S; N M; Pavithran M S; Chidangil S; Lukose J
Exp Eye Res; 2024 Jun; 243():109913. PubMed ID: 38679225
[TBL] [Abstract][Full Text] [Related]
35. Label-free SERS diagnostics of radiation-induced injury via detecting the biomarker Raman signal in the serum and urine bio-samples based on Au-NPs array substrates.
Muhammad M; Shao C; Huang Q
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Dec; 223():117282. PubMed ID: 31247463
[TBL] [Abstract][Full Text] [Related]
36. Electrochemically deposited silver detection substrate for surface-enhanced Raman spectroscopy cancer diagnostics.
Orságová Králová Z; Oriňak A; Oriňaková R; Petruš O; Macko J; Radoňak J; Sukovská Lakyová L; Jurašeková Z; Smith R; Strečková M; Koval K
J Biomed Opt; 2018 Jul; 23(7):1-11. PubMed ID: 29981226
[TBL] [Abstract][Full Text] [Related]
37. Detection of ovarian cancer (± neo-adjuvant chemotherapy effects) via ATR-FTIR spectroscopy: comparative analysis of blood and urine biofluids in a large patient cohort.
Giamougiannis P; Morais CLM; Rodriguez B; Wood NJ; Martin-Hirsch PL; Martin FL
Anal Bioanal Chem; 2021 Aug; 413(20):5095-5107. PubMed ID: 34195877
[TBL] [Abstract][Full Text] [Related]
38. Cancer screening through surface-enhanced Raman spectroscopy fingerprinting analysis of urinary metabolites using surface-carbonized silver nanowires on a filter membrane.
Yu HJ; Jang E; Woo A; Han IW; Jeon HG; Linh VTN; Park SG; Jung HS; Lee MY
Anal Chim Acta; 2024 Mar; 1292():342233. PubMed ID: 38309850
[TBL] [Abstract][Full Text] [Related]
39. Application of SERS-based nanobiosensors to metabolite biomarkers of CKD.
Kukkar D; Chhillar M; Kim KH
Biosens Bioelectron; 2023 Jul; 232():115311. PubMed ID: 37086564
[TBL] [Abstract][Full Text] [Related]
40. Label-Free Sensing with Metal Nanostructure-Based Surface-Enhanced Raman Spectroscopy for Cancer Diagnosis.
Constantinou M; Hadjigeorgiou K; Abalde-Cela S; Andreou C
ACS Appl Nano Mater; 2022 Sep; 5(9):12276-12299. PubMed ID: 36210923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
